leisure time -WSS

leisure time

author：hotspot 2025-09-27 13:10:10 - browse：758

A psilocybin mushroom lays inside a clear capsule — Adobe

A single dose of psilocybin may have enduring benefits for people with major depressive disorder, according to a randomized clinical trial published Thursday in the Journal of the American Medical Association.

Several prior studies have suggested that psilocybin, the psychedelic compound produced by certain types of mushrooms, could be a promising way to treat major depression in people for whom antidepressants or counseling aren’t effective. But those studies mostly focused on short-term results, while the new JAMA study looked at psilocybin’s efficacy up to six weeks after the administration of a single dose of psilocybin.

“It’s exciting to see another study that’s coming out that is adding to the evidence base suggesting potential efficacy of psilocybin for depression, amongst other conditions,” said Greg Fonzo, an assistant professor and co-director for the Center for Psychedelic Research and Therapy at the University of Texas at Austin’s Dell Medical School, who was not involved in the study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： CDC backtracks, saying fully vaccinated people can go maskless indoors

WSS

How artificial intelligence is being used to detect, treat cancer

7 of the most gruesome medical devices in history

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Why an extreme heat and wildfire smoke combination can be so dangerous

CDC launches VaccineFinder tool to locate Covid

Organ transplantation is at a crossroads. Major reform is needed

explore

leisure time

focus

Psychedelics group wrestles with new pharma identity

Sage's campaign to raise awareness of postpartum depression hits a nerve

BioMarin wins approval for gene therapy to treat hemophilia A

New rules on organ donation and transplantation 'will bring chaos'

Medicare proposal to cover medical devices draws a mixed reaction

As Taiwan prepares for anti

Drug repurposing or repositioning? The language matters

How artificial intelligence is being used to detect, treat cancer

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Ohioans vote in high

Wikipedia

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Hospitals use virtual reality to design more inclusive rooms for kids

Travel bans should be based on evidence, not politics or fear

Providers still hesitate to prescribe buprenorphine, study finds

hotspot

explore

hotspot

hotspot